RANOLAZINE
NDC 72319-022 · i3 Pharmaceuticals, LLC
Generic nameRANOLAZINE
Dosage formTABLET, FILM COATED, EXTENDED RELEASE
RouteORAL
Active ingredient(s)RANOLAZINE
Strength1000 mg/1
Pharmacologic classAnti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
Marketing categoryANDA
Packages
72319-022-02 — 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72319-022-02)
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
70625-207 — RANOLAZINE, 70756-703 — Ranolazine, 70756-704 — Ranolazine, 70771-1499 — Ranolazine, 70771-1500 — Ranolazine, 71205-867 — Ranolazine, 71205-868 — Ranolazine, 71335-2556 — RANOLAZINE, 71610-518 — RANOLAZINE, 71610-971 — RANOLAZINE, 72319-021 — RANOLAZINE, 72578-064 — Ranolazine, 72578-065 — Ranolazine, 73141-021 — RANOLAZINE, 73141-022 — RANOLAZINE, 77771-423 — RANOLAZINE, 77771-424 — RANOLAZINE, 82804-118 — Ranolazine, 90096-151 — ranolazine, 90096-152 — ranolazine, +34 more